Compare MKSI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MKSI | RGEN |
|---|---|---|
| Founded | 1961 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.4B | 8.1B |
| IPO Year | 1997 | 1995 |
| Metric | MKSI | RGEN |
|---|---|---|
| Price | $213.60 | $113.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 11 |
| Target Price | ★ $256.00 | $173.09 |
| AVG Volume (30 Days) | ★ 1.4M | 788.0K |
| Earning Date | 05-19-2026 | 05-27-2026 |
| Dividend Yield | ★ 0.45% | N/A |
| EPS Growth | 55.52 | ★ 286.96 |
| EPS | ★ 4.37 | 0.86 |
| Revenue | ★ $3,931,000,000.00 | $141,236,000.00 |
| Revenue This Year | $15.64 | $14.11 |
| Revenue Next Year | $10.58 | $14.71 |
| P/E Ratio | ★ $51.33 | $138.80 |
| Revenue Growth | 9.62 | ★ 35.10 |
| 52 Week Low | $54.84 | $102.97 |
| 52 Week High | $269.91 | $175.77 |
| Indicator | MKSI | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 40.33 | 28.23 |
| Support Level | $212.91 | $113.07 |
| Resistance Level | $246.35 | $132.51 |
| Average True Range (ATR) | 10.69 | 6.60 |
| MACD | -5.08 | -0.48 |
| Stochastic Oscillator | 14.11 | 4.41 |
MKS Inc delivers foundational technology solutions for leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. The company provides instruments, components, subsystems, systems, process control solutions, and specialty chemicals technology that improve process performance and optimize productivity. Its solutions address challenges of miniaturization and complexity in device manufacturing, enabling increased power, speed, and feature enhancement. MKS Inc operates through three divisions: Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Materials Solutions Division (MSD). The company operates in the United States, which generates maximum revenue, as well as China and other countries.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.